Nautilus Biotechnology (NASDAQ:NAUT) reported third-quarter revenue of $200,000 as it continued its transition toward ...
Full-year 2026 revenue guidance was raised to exceed the prior outlook of approximately $500,000 due to increased early access and grant activity. Current cash equivalents of $114.3 million are ...
BioSpectrum India on MSN
Beyond the spin: Can Indian centrifuge makers move up the technology curve?
Centrifugation is evolving beyond rotational speed, capacity and price, with laboratories increasingly prioritising precision ...
Lab-grown protein that mimics the color, taste and texture of meat. Egg white substitutes used for baked goods. Food ...
Stockhead on MSN
AnteoTech builds traction in life sciences business
AnteoTech is growing its life sciences business focused on in vitro diagnostics with its core product AnteoBind. ... Read ...
Vir Biotechnology is approaching multiple clinical readouts from drugs with positive data previously. Click here to read an ...
ROCKVILLE, United States, October 27th, 2026, FinanceWireVitroVivo Biotech LLC, a biotechnology company specializing in ...
All 120 planned participants randomized across five clinical sites in the United StatesRaanana, Israel, Oct. 27, 2026 (GLOBE NEWSWIRE) -- ...
Quarterly operating expenses rose 10% year over year to $16.9 million; cash, equivalents and investments totaled $114.3 million at Sept. 30.
The next major breakthrough in life sciences may have a company’s name attached to it, but increasingly, the story behind ...
Using tariffs as tools of trade policy, the United States (U.S.) government has imposed a 100% tariff on imported branded or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results